![Marcio Souza](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marcio Souza
Chief Executive Officer at
PRAXIS PRECISION MEDICINES, INC.
Net worth: 28 M $ as of 31/05/2026
Profile
Marcio Souza is President, Chief Executive Officer & Director at Praxis Precision Medicines, Inc. since 2020.
Mr. Souza is Director at Remagine Labs, Inc. Former roles include Executive Director-Marketing at NPS Pharmaceuticals, Inc. from 2012 to 2014, Independent Director at Spyre Therapeutics, Inc. from 2021 to 2023, Independent Director at ClearPoint Neuro, Inc. in 2020, Director at ClearPoint Neuro, Inc., and Chief Operating Officer at PTC Therapeutics, Inc. from 2017 to 2020.
Education includes an MBA from Fundação Dom Cabral and undergraduate studies at the University of Sao Paulo.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/05/2026 | 79,616 ( 0.29% ) | 28 M $ | 31/05/2026 |
Marcio Souza active positions
| Companies | Position | Start |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Chief Executive Officer | 01/04/2020 |
Former positions of Marcio Souza
| Companies | Position | End |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Director/Board Member | 22/06/2023 |
| CLEARPOINT NEURO, INC. | Director/Board Member | 27/04/2020 |
| PTC THERAPEUTICS, INC. | Chief Operating Officer | 01/04/2020 |
| NPS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/07/2014 |
| CLEARPOINT NEURO, INC. | Director/Board Member | - |
Training of Marcio Souza
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
32
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Fundação Dom Cabral
 Fundação Dom Cabral Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
University of Sao Paulo
 University of Sao Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clearpoint Neuro, Inc.
 Clearpoint Neuro, Inc. Medical SpecialtiesHealth Technology Develops and markets bio technology and surgical products | Health Technology |
Praxis Precision Medicines, Inc.
 Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
- Stock Market
- Insiders
- Marcio Souza
